Director TitleAgeSince
Director/Board Member - -
Director/Board Member - 27/09/2013
Chairman - -
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%-20.59% - - 2.32Cr
+3.90%-0.39%+376.72%+599.59% 3.96TCr
-1.70%+4.46%+7.46%+57.67% 3.47TCr
-2.01%-0.76%+26.35%-6.83% 3.44TCr
+0.06%+0.34%+2.32%+29.30% 2.71TCr
+0.46%-3.49% - - 1.62TCr
-0.04%-0.09%+68.48%+117.39% 1.54TCr
+1.12%+1.91%+15.90%+19.65% 1.41TCr
0.00%+1.36%+15.74%-30.62% 1.3TCr
-0.08%-3.01%+1,271.69%+649.69% 1.18TCr
Average +0.30%+0.04%+223.08%+179.48% 2.29TCr
Weighted average by Cap. +0.24%+0.36%+171.43%+187.42%
Logo Pharmadax Inc.
Pharmadax Inc is a Taiwan-based company principally engaged in the development, licensing and sales of Abbreviated New Drug Application (ANDA) drugs. The Company is mainly engaged in the development of oral solid extended-release dosage forms and products. The Company's main product is the hypoglycemic product, Glyburide. The Company distributes its products to the United States.
Employees
-
  1. Stock Market
  2. Stocks
  3. 4191 Stock